Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population

Current Oncology Reports

Volumn 11, Issue 4, 2009, Pages 314-321

  Rink, Lori ^a   Godwin, Andrew K ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFIBROMIN; NILOTINIB; NVP AEW 541; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR RECEPTOR; SUNITINIB;

ADJUVANT THERAPY; AGE DISTRIBUTION; CANCER LOCALIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPITHELIOID CELL; EXON; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; INTESTINE NECROSIS; MULTIPLE CYCLE TREATMENT; PEDIATRICS; PROTEIN PHOSPHORYLATION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; CHILD; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; YOUNG ADULT;

EID: 67649391047     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0044-0     Document Type: Review

References (42)

1. Corless CL, Heinrich MC: Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 2007, 3: 557-586.
2. Mazur MT, Clark HB: Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983, 7: 507-519.
3. Rubin BP: Gastrointestinal sAromal tumours: an update. Histopathology 2006, 48: 83-96.
4. Sircar K, Hewlett BR, Huizinga JD, et al.: Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999, 23: 377-389.
5. Kindblom LG, Remotti HE, Aldenborg F, et al.: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998, 152: 1259-1269.
6. El-Rifai W, Sarlomo-Rikala M, Andersson LC, et al.: DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance. Cancer Res 2000, 60: 3899-3903.
7. Tworek JA, Appelman HD, Singleton TP, et al.: Stromal tumors of the jejunum and ileum. Mod Pathol 1997, 10: 200-209.
8. Tworek JA, Goldblum JR, Weiss SW, et al.: Stromal tumors of the anorectum: A clinicopathologic study of 22 cases. Am J Surg Pathol 1999, 23: 946-954.
9. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al.: Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999, 23: 1109-1118.
10. Fang FC, Tzao C, Cheng YL, et al.: Surgical treatment of gastrointestinal stromal tumor in the esophagus: Report of three cases. Z Gastroenterol 2007, 45: 1252-1256.
11. Tarn C, Merkel E, Canutescu AA, et al.: Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: Therapeutic implications through protein modeling. Clin Cancer Res 2005, 11: 3668-3677.
12. DeMatteo RP, Lewis JJ, Leung D, et al.: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000, 231: 51-58.
13. Demetri GD, von Mehren M, Blanke CD, et al.: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002, 347: 472-480.
14. Debiec-Rychter M, Sciot R, Le Cesne A, et al.: KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 2006, 42: 1093-1103.
15. Miettinen M, Lasota J, Sobin LH: Gastrointestinal stromal tumors of the stomach in children and young adults: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 2005, 29: 1373-1381.
16. Prakash S, Sarran L, Socci N, et al.: Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 2005, 27: 179-187.
17. Janeway KA, Liegl B, Harlow A, et al.: Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Cancer Res 2007, 67: 9084-9088.
18. Agaram NP, Laquaglia MP, Ustun B, et al.: Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res 2008, 14: 3204-3215.
19. Orosz Z, Tornoczky T, Sapi A: Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases. Pathol Oncol Res 2005, 11: 11-21.
20. Rauf F, Bhurgri Y, Pervez SA Gastrointestinal stromal tumors: a demographic, morphologic and immunohistochemical study. Indian J Gastroenterol 2007, 26: 214-216.
21. Koay MH, Goh YW, Iacopetta B, et al.: Gastrointestinal stromal tumours (GISTs): A clinicopathological and molecular study of 66 cases. Pathology 2005, 37: 22-31.
22. Corless CL, Fletcher JA, Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 2004, 22: 3813-3825.
23. Cypriano MS, Jenkins JJ, Pappo AS, et al.: Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer 2004, 101: 39-50.
24. Sauseng W, Benesch M, Lackner H, et al.: Clinical, radiological, and pathological findings in four children with gastrointestinal stromal tumors of the stomach. Pediatr Hematol Oncol 2007, 24: 209-219.
25. Price VE, Zielenska M, Chilton-MacNeill S, et al.: Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs). Pediatr Blood Cancer 2005, 45: 20-24.
26. Liegl B, Hornick JL, Corless CL, Fletcher CD: Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 2009, 33: 437-446.
27. Kuroiwa M, Hiwatari M, Hirato J, et al.: Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. J Pediatr Surg 2005, 40: 1798-1801.
28. O'sullivan MJ, McCabe A, Gillett P, et al.: Multiple gastric stromal tumors in a child without syndromic association lacks common KIT or PDGFRalpha mutations. Pediatr Dev Pathol 2005, 8: 685-689.
29. Li P, Wei J, West AB, et al.: Epithelioid gastrointestinal stromal tumor of the stomach with liver metastases in a 12-year-old girl: Aspiration cytology and molecular study. Pediatr Dev Pathol 2002, 5: 386-394.
30. Muniyappa P, Kay M, Feinberg L, et al.: The endoscopic appearance of a gastrointestinal stromal tumor in a pediatric patient. J Pediatr Surg 2007, 42: 1302-1305.
31. Kerr JZ, Hicks MJ, Nuchtern JG, et al.: Gastrointestinal autonomic nerve tumors in the pediatric population: A report of four cases and a review of the literature. Cancer 1999, 85: 220-230.
32. Andersson J, Sihto H, Meis-Kindblom JM, et al.: NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 2005, 29: 1170-1176.
33. Delemarre L, Aronson D, van Rijn R, et al.: Respiratory symptoms in a boy revealing Carney triad. Pediatr Blood Cancer 2008, 50: 399-401.
34. Carney JA, Sheps SG, Go VL, et al.: The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977, 296: 1517-1518.
35. Carney JA: Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): Natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999, 74: 543-552.
36. Horenstein MG, Hitchcock TA, Tucker JA: Dual CD117 expression in gastrointestinal stromal tumor (GIST) and paraganglioma of Carney triad: a case report. Int J Surg Pathol 2005, 13: 87-92.
37. Tarn C, Rink L, Merkel E, et al.: Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A 2008, 105: 8387-8392.
38. Belinsky MG, Rink L, Cai KQ, et al.: The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell Cycle 2008, 7: 2949-2955.
39. Godwin AK, Rink L, Chi T, et al.: Insulin-like growth factor 1 receptor (IGF-1R): A potential therapeutic target for gastrointestinal stromal tumors (GIST) [abstract]. J Clin Oncol 2008, 26(May 20 Suppl): 10507.
40. Bond M, Bernstein ML, Pappo A, et al.: A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study. Pediatr Blood Cancer 2008, 50: 254-258.
41. Hayashi Y, Okazaki T, Yamataka A, et al.: Gastrointestinal stromal tumor in a child and review of the literature. Pediatr Surgery Int 2005, 21: 914-917.
42. Janeway KA, Matthews DC, Butrynski JE, et al.: Sunitinib treatment of pediatric metastatic GIST after failure of imatinib [abstract]. J Clin Oncol 2006, 24(18S Suppl): 9519.